Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022

This report describes the ACIP recommendations for two doses of RZV to prevent herpes zoster and related complications in immunocompromised adults.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Adult Health Adult Vaccinations Advisory Committee on Immunization Practices (ACIP) MMWR Morbidity & Mortality Weekly Report Shingles (Herpes Zoster) Shingles Vaccination Source Type: news